Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > ANGIOTENSINII,HUMAN for Sale > Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - large image1
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image1
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image2
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image3
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image4
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image5
Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial buy - image6

Research-Only Retatrutide Lyophilized Peptide Powder, 10mg Loading Per Vial

Unit Price:

$53/UNIT EXW

Get Latest Price
CAS No.:

4474-91-3

Grade:

Research Grade

Content:

99%

Port:

qingdao

Brand:

Peptide

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2026-11-19

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • Description


      Product Detail  


    Company Profile

    Our enterprise focuses on developing and supplying synthetic peptide raw materials for life science laboratory research. We have built standardized production workflows and assembled an experienced technical and sales team. We can tailor raw material solutions according to each lab’s experimental design, serving researchers across multiple regions worldwide.

    We uphold integrity and consistent product performance as our core principles. We keep track of evolving needs within the research community and adjust our inventory and supply plans accordingly. From initial consultation and order confirmation through production scheduling and dispatch, we aim to deliver streamlined service for every submission.

    Product Details

    This product line comprises research-grade synthetic peptide lyophilized powder, manufactured via chemical synthesis followed by freeze-drying processing. The lyophilization process lowers moisture levels, slows molecular degradation, and helps preserve material stability over storage.

    Each batch features fine, homogeneous powder that dissolves readily in compatible solvents, with low impurity profiles and consistent performance across production runs. It serves as a reliable material for biochemical assays, in vitro experiments and academic research projects.

    We support small trial batches as well as large-volume orders. Unit pricing becomes more competitive for larger quantities. Custom packaging arrangements can also be discussed to accommodate different laboratory operational preferences.

    Product Consistency

    We maintain careful oversight throughout the whole production workflow. Starting materials are sourced from qualified suppliers and reviewed before entering production.

    Synthesis and purification follow established operating procedures. Finished materials undergo multiple analytical assessments to confirm purity, moisture content and impurity profiles.

    Materials are cleared for dispatch once evaluation criteria are met. Batch records are retained, and relevant supporting documentation can be shared to support your research records upon request.

    Packaging and Logistics

    Our inner packaging uses professional light-blocking sealed vials. Outer packaging includes protective cushioning to reduce mechanical shock and temperature variation risks during transit.

    We work with trusted international logistics partners. Shipment will be arranged within 1–2 business days after payment confirmation, and a tracking number will be provided for shipment monitoring.

    Support Services

    Our sales and technical team provides dedicated support for laboratory buyers and responds to inquiries within 24 business hours.

    You may reach out for guidance on product selection, storage recommendations, order updates or packaging preferences. Custom labeling and repackaging options can be explored where feasible.

    After shipment, we continue tracking delivery progress. Please contact us promptly if any issues arise upon receipt, and we will work toward a suitable resolution.

    Storage Conditions

    Store in a cool, dry, dark, low-temperature environment. Avoid repeated freeze-thaw cycles. We recommend aliquoting materials based on experimental usage to help maintain sample integrity.

    Important Disclaimer

    This product is intended exclusively for in vitro laboratory research. It may NOT be used for human, clinical, diagnostic, medical, cosmetic, food or feed applications. The purchaser shall bear responsibility to ensure the product is used solely within permitted laboratory research scope.

    Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 1 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 2 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 3 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 4

    Items Specifications
    Product type Synthetic peptide
    Grade Research grade
    Purity ≥99%
    Appearance White / off‑white lyophilized powder
    Package form Sealed glass vials
    Available experimental sizes 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 500 mg
    Minimum order 1 kit (10 vials)
    ECHEMI Editorial Reference
    Angiotensin II human is a vasoconstrictor that acts on the AT1 and the AT2 receptor.
    Solid
    Ile(5)-angiotensin II is an angiotensin II that acts on the central nervous system (PDB entry: 1N9V). It has a role as a human metabolite. It is a tautomer of an Ile(5)-angiotensin II dizwitterion.|Angiotensin II is under investigation for the treatment of Sepsis, Septic Shock, Diabetes Mellitus, and Acute Renal Failure. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy. As of December 21, 2017 the FDA approved La Jolla Pharmaceutical's Giapreza (angiotensin II) Injection for Intravenouse Infusion for the indication of acting as a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock. The novelty of the medication lies in the fact that it is the first and only use of synthetic human angiotensin II to help maintain body blood pressure. Shock is the inability to maintain blood flow to vital tissues and the potential resultant organ failure and death within hours, no matter young or o ld. As distributive shock is the most common type of shock in the inpatient setting and affects up to one third of patients in the intensive care unit, the FDA determined that there is a need for treatment options for critically ill hypotensive patients who do not adequately respond to currently available therapies.|Angiotensin ii is a Vasoconstrictor. The physiologic effect of angiotensin ii is by means of Vasoconstriction.|Therapeutic Angiotensin II is a synthetic form of the endogenous angiotensin II, a peptide hormone of the renin-angiotensin-aldosterone system (RAAS) that causes vasoconstriction and an increase in blood pressure, that may be used for the treatment of septic or other distributive shock. Upon administration, therapeutic angiotensin II binds to angiotensin II type 1 receptor on vascular smooth muscle cells which leads to Ca2+/calmodulin-dependent phosphorylation of myosin. This causes smooth muscle contraction and results in vasoconstriction and an increase in blood pressure. Therapeutic angiotensin II also increases blood pressure by stimulating the release of the steroid hormone aldosterone, which regulates the renal absorption of water and sodium.|An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.

    Basic Info
    Product Name:

    ANGIOTENSINII,HUMAN

    Other Name:

    AngII;DRVYIHPF;TY-10721;ANGIOTENSIN-2;ANGIOTENSINII;ANTI-ANGIOTENSINII;ile(5)-angiotensini;[ILE5]-ANGIOTENSIN2;angiotensinii(mouse);[Ile5]angiotensinII

    CAS No.:

    4474-91-3

    Molecular Formula:

    C50H71N13O12

    InChIKeys:

    CZGUSIXMZVURDU-JZXHSEFVSA-N

    Molecular Weight:

    1046.18

    Exact Mass:

    1045.534546

    EC Number:

    2017-001-1

    UNII:

    M089EFU921

    DSSTox ID:

    DTXSID4036778|DTXSID30196288

    NCI Thesaurus Code:

    C173802

    ATC Code:

    C09|C - Cardiovascular system

    Categories:

    Polypeptide

    Characteristics
    PSA:

    406.34000

    XLogP3:

    2.34

    Appearance:

    orange Powder

    Density:

    1.4±0.1 g/cm3

    Boiling Point:

    809.08°C (rough estimate)

    Refractive Index:

    1.664

    Water Solubility:

    soluble in water (25 mg/ml), and 5% Acetic Acid (1 mg/ml).

    Storage Conditions:

    −20°C

    Collision Cross Section:

    353.79 Ų [M+2H]2+ [CCS Type: DT, Method: stepped-field]|436.24 Ų [M+3H]3+ [CCS Type: DT, Method: stepped-field]|314.38 Ų [M+H]+ [CCS Type: DT, Method: stepped-field]

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.